GENZ-882706 (Raceme) is primarily utilized in the field of medical research, particularly in the development of therapeutic agents targeting specific diseases. Its application is focused on studying its potential as a modulator of biological pathways, which could lead to the treatment of conditions such as metabolic disorders or neurodegenerative diseases. Researchers explore its efficacy and safety profile in preclinical models to determine its suitability for further clinical trials. Additionally, it serves as a valuable tool in pharmacological studies to understand drug interactions and mechanisms of action, aiding in the optimization of new drug candidates.